Literature DB >> 10644606

Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats.

S Hoshida1, N Yamashita, K Otsu, T Kuzuya, M Hori.   

Abstract

We measured infarct size after coronary occlusion (30 min) and reperfusion (24 h) in genetic non-insulin-dependent Zucker diabetic fatty (ZDF) rats with and without 4-wk cholesterol feeding. Infarct size was similar in ZDF rats and lean control rats but was significantly larger in cholesterol-fed diabetic rats than in cholesterol-fed lean rats (P < 0.05). Plasma levels of glucose, insulin, and triglycerides were significantly higher in diabetic rats and were not influenced by cholesterol feeding. The increase in total plasma cholesterol induced by cholesterol feeding was significantly greater in diabetic rats than in lean rats (P < 0.05). A significant positive correlation was found between total plasma cholesterol and infarct size (P < 0.05). Myeloperoxidase activity, as an index of neutrophil accumulation, was significantly higher and expression of P-selectin was more marked in the ischemic myocardium of cholesterol-fed diabetic rats than of cholesterol-fed lean rats. Acetylcholine-induced endothelium-dependent relaxation (EDR) of aortic rings was markedly impaired in cholesterol-fed diabetic rats. Thus cholesterol feeding significantly exacerbated myocardial injury produced by coronary occlusion-reperfusion in non-insulin-dependent diabetic rats, possibly because of enhanced expression of P-selectin and impairment of EDR in the coronary bed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644606     DOI: 10.1152/ajpheart.2000.278.1.H256

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

Review 1.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

Review 2.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury.

Authors:  A Adameová; M Kuzelová; E Andelová; V Faberová; D Pancza; P Svec; A Ziegelhöffer; T Ravingerová
Journal:  Mol Cell Biochem       Date:  2006-08-10       Impact factor: 3.396

Review 4.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

5.  Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion.

Authors:  Robert M Osipov; Cesario Bianchi; Jun Feng; Richard T Clements; Yuhong Liu; Michael P Robich; Hilary P Glazer; Neel R Sodha; Frank W Sellke
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

Review 6.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

7.  Low-density lipoprotein receptor gene transfer in hypercholesterolemic mice improves cardiac function after myocardial infarction.

Authors:  E Van Craeyveld; F Jacobs; S C Gordts; B De Geest
Journal:  Gene Ther       Date:  2011-10-06       Impact factor: 5.250

8.  Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury.

Authors:  Niek J Pluijmert; Melina C den Haan; Vanessa L van Zuylen; Paul Steendijk; Hetty C de Boer; Anton J van Zonneveld; Willem E Fibbe; Martin J Schalij; Paul H A Quax; Douwe E Atsma
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

Review 9.  Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.

Authors:  Charissa E van den Brom; Carolien Se Bulte; Stephan A Loer; R Arthur Bouwman; Christa Boer
Journal:  Cardiovasc Diabetol       Date:  2013-03-04       Impact factor: 9.951

10.  High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.

Authors:  M B P Landim; P M M Dourado; A Casella-Filho; A C P Chagas; P L da-Luz
Journal:  Braz J Med Biol Res       Date:  2013-05-10       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.